Skip to main navigation Skip to search Skip to main content

A Phase 4, Open-Label, Prospective Study in Patients with Pompe Disease to Evaluate the Efficacy and Safety of Alglucosidase Alfa (study drug) Produced at the 4000 L Scale

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date03/29/12 → 03/28/16

Funding

  • Genzyme Corporation: $89,200.45